(Q33371277)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716135%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

0 references

1 reference

title

Pharmacokinetics of intravenous immunoglobulin: a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716135%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716135%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Tamar Koleba

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716135%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

language of work or name

English

0 references

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716135%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716135%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716135%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716135%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

813-827

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16716135%20AND%20SRC:MED&resulttype=core&format=json

IVIG--mechanisms of action.

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Antibody pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Intravenous immune globulin therapy in hypogammaglobulinemia. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Thrombosis complicating high dose intravenous immunoglobulin: report of three cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Responding to the immunoglobulin shortage: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Familial hypercatabolic hypoproteinemia. A disorder of endogenous catabolism of albumin and immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Human intravenous immunoglobulin in primary and secondary antibody deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Increase of serum immunoglobulin level into the normal range in primary hypogammaglobulinaemia by dosage individualization of intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Safety, efficacy, and pharmacokinetics of Flebogamma 5% [immune globulin intravenous (human)] for replacement therapy in primary immunodeficiency diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Pharmacokinetics of intravenous immunoglobulin (Gammagard) in bone marrow transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Replacement therapy with modified immunoglobulin G in burn patients: preliminary kinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Antenatal treatment of neonatal alloimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Continuing controversy in alloimmune thrombocytopenia: fetal hyperimmunoglobulinemia fails to prevent thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Intravenous gammaglobulin therapy for prophylaxis of infection in high-risk neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Disposition of an immunoglobulin intravenous preparation in very low birth weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813

Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.813